ANNX
USDAnnexon Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$2.660
고가
$2.670
저가
$2.510
거래량
1.85M
기업 기본 정보
시가총액
276.5M
산업
생명공학
국가
United States
거래 통계
평균 거래량
1.80M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ:ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical
HC Wainwright & Co. Maintains Buy on Annexon, Lowers Price Target to $14
HC Wainwright & Co. analyst Andrew Fein maintains Annexon with a Buy and lowers the price target from $20 to $14.
관련 주식
TCBIO
Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B
QRTEA
Qurate Retail Inc. Series A
WTRG
Essential Utilities Inc.
EMD
Western Asset Emerging Markets Debt Fund Inc
ACV
Virtus Diversified Income & Convertible Fund Common Shares of Beneficial Interest
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기